84388 studies found for:    United States
Show Display Options
Rank Status Study
1 Completed
Has Results
Trial of Decitabine in Patients With Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Drug: Cytarabine or Supportive Care;   Drug: Dacogen (decitabine) only
2 Active, not recruiting Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer
Conditions: Recurrent Uterine Sarcoma;   Uterine Carcinosarcoma
Interventions: Drug: ixabepilone;   Other: laboratory biomarker analysis
3 Completed Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: dexamethasone;   Drug: pamidronate disodium;   Drug: thalidomide;   Drug: zoledronic acid
4 Completed
Has Results
Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%
Condition: Acne Vulgaris
Interventions: Drug: Adapalene lotion 0.1%;   Drug: Adapalene Lotion Vehicle
5 Recruiting To Evaluate the Safety, Tolerability and Efficacy of Calcipotriene Foam, 0.005%, Versus Vehicle Foam in Pediatric Subjects (Ages 2-11) With Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: STF 115469 Foam;   Drug: Vehicle Foam
6 Active, not recruiting A Study To Evaluate The Safety And Tolerability Of PF-06342674 (RN168) In Subjects With Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Interventions: Biological: PF-06342674 0.25 mg/kg;   Biological: Placebo;   Biological: PF-06342674 1.5 mg/kg;   Biological: PF-06342674 6.0 mg/kg
7 Recruiting Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission
Condition: Childhood Acute Lymphoblastic Leukemia in Remission
Interventions: Behavioral: behavioral intervention;   Drug: mercaptopurine;   Procedure: standard follow-up care;   Behavioral: compliance monitoring;   Other: questionnaire administration;   Other: laboratory biomarker analysis
8 Completed Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART
Condition: HIV Infections
Interventions: Drug: Amprenavir/ritonavir;   Drug: Saquinavir/ritonavir;   Drug: Efavirenz
9 Completed
Has Results
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation
Condition: Cystic Fibrosis
Interventions: Drug: Ivacaftor;   Drug: Placebo
10 Completed Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
Conditions: Mycobacterium Avium-intracellulare Infection;   HIV Infections
Intervention: Drug: Rifabutin
11 Completed STI571 in Treating Patients With Recurrent Leukemia
Condition: Leukemia
Intervention: Drug: imatinib mesylate
12 Active, not recruiting
Has Results
Carotid Revascularization Endarterectomy Versus Stenting Trial
Conditions: Atherosclerosis;   Stroke;   Carotid Stenosis;   Cerebral Infarction;   Myocardial Infarction
Interventions: Procedure: Carotid Endarterectomy (CEA);   Device: Carotid Artery Stenting (CAS)
13 Completed
Has Results
Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration
Conditions: Age-Related Maculopathy;   Age-Related Maculopathies;   Eye Diseases;   Retinal Degeneration;   Macular Degeneration
Interventions: Biological: RN6G;   Biological: Placebo
14 Recruiting HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer
Condition: Hepatocellular Carcinoma
Interventions: Device: HepaSphere/QuadraSphere Microspheres;   Procedure: PVA, lipiodol, doxorubicin
15 Completed
Has Results
A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension
Condition: Hypertension
Interventions: Drug: irbesartan;   Drug: placebo;   Drug: PS433540
16 Active, not recruiting Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants
Condition: Bronchopulmonary Dysplasia
Interventions: Drug: Inhaled Nitric Oxide;   Drug: Placebo
17 Completed
Has Results
Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia
Condition: Chronic Insomnia
Interventions: Drug: Ramelteon and zolpidem;   Drug: Placebo and zolpidem
18 Recruiting Pediatric Obesity Weight Evaluation Registry (POWER) Study
Conditions: Overweight;   Obesity
Intervention:
19 Completed
Has Results
An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041)
Condition: Chronic Angina
Intervention: Drug: Ranolazine
20 Completed Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Radiation: radiation therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years